ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,938,000 | -9.1% | 638,086 | 0.0% | 1.56% | -4.0% |
| Q3 2016 | $8,735,000 | +36.0% | 638,086 | -26.6% | 1.62% | +32.0% |
| Q2 2016 | $6,423,000 | +24.5% | 869,100 | +7.7% | 1.23% | +26.9% |
| Q1 2016 | $5,157,000 | +2.2% | 807,100 | 0.0% | 0.97% | +3.3% |
| Q4 2015 | $5,044,000 | +1.6% | 807,100 | -5.0% | 0.94% | -0.1% |
| Q3 2015 | $4,964,000 | -50.0% | 850,000 | -29.2% | 0.94% | -44.6% |
| Q2 2015 | $9,924,000 | +0.4% | 1,200,000 | 0.0% | 1.69% | +7.1% |
| Q1 2015 | $9,888,000 | +19.9% | 1,200,000 | 0.0% | 1.58% | +46.4% |
| Q4 2014 | $8,244,000 | +27.2% | 1,200,000 | 0.0% | 1.08% | +23.7% |
| Q3 2014 | $6,480,000 | – | 1,200,000 | – | 0.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $82,111,000 | 18.09% |
| Consonance Capital Management LP | 5,575,742 | $35,629,000 | 5.39% |
| Opaleye Management Inc. | 1,250,000 | $7,988,000 | 4.98% |
| Tamarack Advisers, LP | 1,600,000 | $10,224,000 | 3.58% |
| Camber Capital Management LP | 5,405,235 | $34,539,000 | 2.02% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 324,636 | $2,074,000 | 1.36% |
| Palo Alto Investors LP | 2,248,317 | $14,367,000 | 1.12% |
| 1492 Capital Management LLC | 202,500 | $1,294,000 | 1.09% |
| Geduld E E | 120,100 | $767,000 | 1.05% |
| JS Capital Management LLC | 868,700 | $5,551,000 | 1.00% |